Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 2 7Phase 3 3Phase 4 2Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Colorectal Neoplasms 2Weight Loss 1Sleep Initiation and Maintenance Disorders 1Protein Deficiency 1Prostatic Neoplasms 1Prolactinoma 1Neoplastic Cells, Circulating 1Neoplasms 1Multiple Myeloma 1Melanoma 1Malnutrition 1Kidney Neoplasms 1Iron Deficiencies 1Hemostasis 1Delirium 1Carcinoma, Renal Cell 1Anemia 1

Interventions

Capecitabine 13Fluorouracil 11Oxaliplatin 10Bevacizumab 9Leucovorin 6Irinotecan 6HMPL-013 4Folfox protocol 4Cetuximab 4ferric carboxymaltose 3regorafenib 2gadolinium ethoxybenzyl DTPA 2gadobenic acid 2Triamcinolone 2Standard of Care 2Sodium Chloride 2Radiofrequency Ablation 2Pirinitramide 2Morphine 2Esomeprazole 2Analgesia, Epidural 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1sodium phosphate 1raltitrexed 1polyethylene glycol 3350 1iron isomaltoside 1000 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1gadoteridol 1gadoterate meglumine 1gadodiamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Colorectal Neoplasms × Standard of Care × Clear all
NCT01468623 2023-07-19

PROFUSE

Myriad Genetic Laboratories, Inc.

Phase 4 Terminated
51 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00496678 2013-08-09

Trial of Patient Navigation-Activation

University of Rochester

Phase 4 Completed
900 enrolled
BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡